curasan Aktie
Personal
2014 | 2015 | 2016 | 2017 | 2018 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 32 | 35 | 34 | 37 | 38 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,19 | 0,16 | 0,19 | 0,18 | 0,15 |
Bilanz (in Mio. EUR) - Aktiva
2014 | 2015 | 2016 | 2017 | 2018 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 6 | 6 | 5 | 8 | 5 |
Summe Anlagevermögen | 8 | 7 | 7 | 7 | 6 |
Summe Aktiva | 14 | 13 | 13 | 15 | 11 |
Bilanz (in Mio. EUR) - Passiva
2014 | 2015 | 2016 | 2017 | 2018 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 0 | 0 | 0 | 0 | 1 |
Summe Fremdkapital | 7 | 4 | 4 | 5 | 4 |
Summe Eigenkapital | 7 | 9 | 9 | 10 | 8 |
Summe Passiva | 14 | 13 | 13 | 15 | 11 |
Adresse
Ernst-Wiss-Strasse 18, 65933 Frankfurt | |
Telefon | +49 (6027) 40900-0 |
Internet | http://www.curasan.com |
Management
Alexander Baratta
Chairman-Supervisory Board |
Alexander Huwig
Chief Scientific Officer |
Andrea Weidner
Head-Corporate Communications |
Christian Brunetti
Chief Sales Officer |
Christine Böhm
Chief Medical Officer |
Dirk Dembski
President & Chief Executive Officer |
Ingo Middelmenne
Head-Investor Relations |
Isabella de Krassny
Vice Chairman-Supervisory Board |
Kurt Berger
Member-Supervisory Board |
Nadja Lüdicke
Operations Director |
Shane Ray
Chief Marketing Officer |